Table 1:

Frequencies, descriptive statistics and standardized differences of each covariate before and after propensity score matching for patients who received hospice palliative care from the Symptom Management Program and a matched control group

CovariateBefore matching; no. (%) of patients*After matching; no. (%) of patients*
SMP
n = 914
Non-SMP
n = 1613
dSMP
n = 754
Non-SMP
n = 754
d
Age group, yr0.580.08
 < 55101 (11.0)68 (4.2)69 (9.2)58 (7.7)
 55–64204 (22.3)180 (11.2)145 (19.2)131 (17.4)
 65–74283 (31.0)356 (22.1)234 (31.0)234 (31.0)
 ≥ 75326 (35.7)1009 (62.6)306 (40.6)331 (43.9)
Sex0.050.00
 Male504 (55.1)926 (57.4)431 (57.2)431 (57.2)
 Female410 (44.9)687 (42.6)323 (42.8)323 (42.8)
Charlson Comorbidity Index score, mean ± SD5.23 ± 2.823.81 ± 2.880.514.91 ± 2.834.92 ± 2.900.01
Duration of disease, yr, mean ± SD3.45 ± 4.396.79 ± 6.350.553.79 ± 4.643.48 ± 4.230.07
Cancer type0.440.07
 Breast59 (6.5)142 (8.8)48 (6.4)49 (6.5)
 Lung264 (28.9)225 (13.9)190 (25.2)170 (22.5)
 Colorectal96 (10.5)232 (14.4)88 (11.7)87 (11.5)
 Prostate67 (7.3)253 (15.7)65 (8.6)64 (8.5)
 Other428 (46.8)761 (47.2)363 (48.1)384 (50.9)
Rural residence0.180.01
 No842 (92.1)1397 (86.6)688 (91.2)687 (91.1)
 Yes72 (7.9)216 (13.4)66 (8.8)67 (8.9)
Income quintile0.140.06
 1 (lowest)208 (22.8)443 (27.5)185 (24.5)165 (21.9)
 2188 (20.6)324 (20.1)159 (21.1)163 (21.6)
 3185 (20.2)269 (16.7)143 (19.0)149 (19.8)
 4175 (19.1)327 (20.3)140 (18.6)147 (19.5)
 5 (highest)158 (17.3)250 (15.5)127 (16.8)130 (17.2)
Index year0.150.02
 2012190 (20.8)407 (25.2)165 (21.9)166 (22.0)
 2013232 (25.4)436 (27.0)203 (26.9)210 (27.8)
 2014228 (24.9)397 (24.6)188 (24.9)183 (24.3)
 2015264 (28.9)373 (23.1)198 (26.3)195 (25.9)
  • Note: d = standardized difference, SD = standard deviation, SMP = Symptom Management Program.

  • * Except where noted otherwise.